JPMorgan raised the firm’s price target on Mettler-Toledo (MTD) to $1,285 from $1,200 and keeps a Neutral rating on the shares as part of a Q3 preview for the life science tools group. The firm sees tools companies taking a more conservative stance on 2026 pending more evidence of order improvement. JPMorgan lowered 2026 numbers for several tools companies into the quarter.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD: